Penny stock picks | research with support and resistance for trading | stock investing
day investing picks penny stock trading
Skip Navigation Links
    Home
    •   About US
    Market Activity
    World Indices
    Market Watch
    Customer Service
    Learning Center
    Economic Event
    Login


Join Now




Advertise 2 my advertising 3 of 5
 

immunogenic Inc support, resistance research

Stock : IMGN |   Stock Recommendations : Buy
Sector : Biotech |   First resistance : 5.55
Stock Name : immunogenic Inc |   Second resistance : 7.00
Buy Near : 3.75 |   Third resistance : 7.37
StopLoss : 3.42 |   First Support : 3.63
Posted date : 5/18/2008 12:00:00 AM |   Second Support : 3.42


Breakout with nice volume, any down move consider as a buying opportunity. CCI and Stockhastic already given a Buy signal. As per my opinion just buy he

   



Penny Stocks



Recent News Head Lines
ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences
(Wed, 25 May 2022 20:30:00 +0000)
WALTHAM, Mass., May 25, 2022--ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences
ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
(Tue, 24 May 2022 13:39:01 +0000)
ImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead candidate, mirvetuximab soravtansine, for treating platinum-resistant ovarian cancer.
ImmunoGen's stock is up 12% after the FDA accepts application for new ovarian-cancer therapy
(Mon, 23 May 2022 11:59:45 +0000)
Shares of ImmunoGen Inc. jumped 12.0% in premarket trading on Monday after the company said the Food and Drug Administration accepted an application for its experimental ovarian-cancer treatment. The mirvetuximab soravtansine monotherapy has a Prescription Drug User Fee Act action date of Nov. 28. ImmuoGen said it is still enrolling patients in a confirmatory trial, with plans to announce data from that study early next year. The company's stock has declined 51.7% this year, while the broader S&
ImmunoGen Announces Acceptance of Biologics License Application for Mirvetuximab Soravtansine in Ovarian Cancer by US Food and Drug Administration with Priority Review
(Mon, 23 May 2022 10:30:00 +0000)
WALTHAM, Mass., May 23, 2022--ImmunoGen Announces Acceptance of Biologics License Application for Mirvetuximab Soravtansine in Ovarian Cancer by US FDA with Priority Review
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming H.C. Wainwright Global Investment Conference
(Tue, 10 May 2022 20:30:00 +0000)
WALTHAM, Mass., May 10, 2022--ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming H.C. Wainwright Global Investment Conference


Never go against major trend for Penny stock trading | investing
  


Home for ۩ Day Trading | Breakout Stock trading system | Penny Stock Investing | Market Research

Contact Us | Affiliate | Disclaimer | Feedback | Help | Site Map | RSS  RSS
All Rights Reserved © 2000-2006 Flyingstock.com
Chart courtesy of StockCharts.com
Penny stock trading- immunogenic Inc for penny stock investing Day Trading

This Service is solely an information service provided by the automated software tool & is for entertainment purposes only. It should be understood that there is no guarantee that past performance of our stock trading system or day trading Strategy or Penny stock picks will be indicative of future results.